GDNF in treatment of Parkinson's disease: response to editorial.
Lang
Anthony E
AE
Langston
J William
JW
Stoessl
A Jon
AJ
Brodsky
Matthew
M
Brooks
David J
DJ
Dhawan
Vijay
V
Elias
William J
WJ
Lozano
Andres M
AM
Moro
Elena
E
Nutt
John G
JG
Stacy
Mark
M
Turner
Dennis
D
Wooten
G Frederick
GF
D002986:Clinical Trials as Topic; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D028701:Patient Rights
D051100:Glial Cell Line-Derived Neurotrophic Factor